We bring together exceptional science, business, startup and finance experience, as well as deep international longevity network.

Petr has been a serial entrepreneur for more than 33 years and believes that science and technology can help humanity reach a new, better level of being. He is building science, funding, and business infrastructure to support faster adoption of health-span improving technologies. He is a founder of Longevitytech.fund, former Entrepreneur in Residence at Singularity University, co-founder of the Longevityforum.eu, board member at Animal Biosciences (US), AgeCurve (UK), iamYiam (UK). He helps innovative teams in the Longevity sector grow into confident companies with global ambitions. He provides advice on fundraising, strategy, and product management. He advises companies as a mentor at Foresight Institute and On Deck Longevity Biotech.

Founder and Editor in Chief of Investicniweb.cz (from 2009) - the leading investment news platform in Czech. 12 year of experience as licensed SE trader at Eastbrokers, Merrill Lynch, Citibank a HVB Bank. He also manages investment fairs like Investment forum and Trading Expo and TV shows O2 TV a Byznys index. He successfully managed his previous real estate fund to more than 200% ROI. He graduated on American Institute of Arts and Science with a specialization on portfolio management (MBA).

Vladislav Severa has spent almost two decades in the field of Corporate Finance, having worked on a number of premiere deals in the CEE region and leading the regional Transaction Advisory team of a Big Four firm, before establishing and leading also its CE Advanced Analytics practice. More recently, Vladislav has been active as a founder or sponsor of AI-aided start-ups in education technology. Vladislav graduated in Physics from Charles University in Prague, where he also earned Ph.D. in Mathematics, and is joining Longevitytech.fund as a co-founder.

Head of IBM Watson AI R&D Lab, Prague. Skilled in managing international research and engineering around AI, natural language processing, speech and conversational technologies. Strong and seasoned professional with a Doctor of Philosophy - PhD focused in Mathematics and Computer Science from Charles University in Prague. Jan has 40+ international patents and many scientific publications around AI.

A scientist, entrepreneur and a lifelong longevity enthusiast. She holds a PhD in biotechnology and her postdoctoral work was in in-vivo delivery systems. She has worked in various sectors of the industry including working as a part of a contract research organization liaising with several ivy league pharma companies in the drug discovery space, as scientific founder and CSO of two startups, and as a consultant in the regenerative medicine and longevity space. In the investing space, she has been a venture consultant,  part of a mid-sized venture fund as the Principal Biologist and Partner. She is currently associated with the Longevity Tech Fund group of companies as the Chief Science Officer and Partner. She has served on several scientific advisory boards and editorial boards, and she brings in scientific expertise, business strategy and management experience with a multicultural multi-country background.

Bill is passionate about human longevity and healthspan. His career as an investor, asset manager, and entrepreneur is supplemented with deep learning in biohacking, health, wellness and the human body. He likes the term longevist as a tagline for now. He likes to use the term futurist as well.
Bill has worked at major financial institutions in the US and Europe like Citigroup and Allianz and also smaller startups and gained extensive experience in IP and deal structuring. He has a computer science undergraduate degree and a finance MBA both from NYU.
His current reading is The Genesis Machine: Our Quest to Rewrite Life in the Age of Synthetic Biology
Age goal: 130+

Expert in pharmaceutical, regulatory, and antitrust law. She leads Taylor Wessing's CEE Life Science team. Before joining Novartis Oncology she spent five years as Head of CEE Competition at CMS Cameron McKenna (during which she was seconded for almost three years to Amazon), two years at Weinhold Legal and four and a half years with Clifford Chance. She studied law in several European cities as well as in Australia and acquired LL.M. Degree from Cambridge University and Ph.D in law from the Charles University in Prague.

CEO of technology transfer office IOCBTech and vice-president of Institute of Organic Chemistry and Biochemistry of Czech Science Academy. He is also the chairman of grant committee of Czech Technology Agency and university professor of biochemistry. His work is rooted in basic research and research commercialization. He authored more than 50 papers and published two monographies.

Professor of environmental chemistry and the director of RECETOX. She has vast research experience in the field of environmental health and the impacts of toxic substances on health. She currently coordinates the CETOCOEN Excellence project, which aims to build a European Center of Excellence for Environmental and Health Research. She has published more than 180 scientific articles, with more than 4000 citations. She acts as an expert in the United Nations Environment Program and the World Health Organization. She has also established research and educational cooperation with several leading international universities such as ETH Zurich, University College London, Stanford, Columbia University, and the University of Saskatchewan.

Josef Loschmidt Chair Professor of Chemistry and Professor of Biochemistry at the Faculty of Science at Masaryk University in Brno, Czech Republic and a group leader at the International Centre for Clinical Research. Research of his group focuses on protein engineering. His group develops new concepts and software tools for protein engineering (CAVER, CAVERDOCK, HOTSPOT WIZARD, PREDICTSNP, FIREPROT, CALFITTER), and uses them for the computational design of enzymes. He has published >200 original articles, 18 book chapters and filed 7 international patents. He is a co-founder of the first biotechnology spin-off from Masaryk University - Enantis Ltd. Among the awards and distinctions, he has received the award EMBO/HHMI Scientist of the European Molecular Biology Organisation and the Howard Hughes Medical Institute.

Senior research scientist at Technical University Munich, Germany. He is working to understand the links between cancer and the aging process using his expertise in stem cells, high throughput sequencing technologies, and bioinformatics analysis. He was associated with the SENS research foundation and followed scientific development in the longevity field for many years. He has 10+ years of international research experience including a Ph.D. in Molecular Medicine from the German center for neurodegenerative diseases and the University of Goettingen in Germany. He authors in several high impact factor peer-reviewed publications such as Nature Neuroscience, Human molecular genetics, etc. He is also an entrepreneur and member of the Longevity investor network at Life extension advocacy foundation (LEAF) where he provides scientific assessments for longevity startups. He is also a founding member of the Longevity Accelerator.

A doctor with 30 years of experience in elite sports, especially in the field of fitness and bodybuilding. A specialist in athlete supplementation, a certified consultant and the head of an outpatient clinic in nutrition genetics, pharmacogenetics, sports and lifestyle genetics. Has worked for several international pharmaceutical companies (Glaxo, Yamanouchi, Krewel Meuselbach) and for the Czech Genetic Laboratory (Vemodia, KitGen), cooperating partner of several renowned European and American companies dealing with DNA analysis and telomere biology (DNA Plus, Novogenia, Life Length, T.A. Science). Physician of the Center for Medical Provision of Sports Representation in ÚVN Prague. A member of A4M (American Academy of Anti aging Medicine).

A generalist interested in building a better future. Co-founder of Longevityforum.eu, discussion platform aiming to bring the longevity topic into the mainstream starting in Czechia. He's written articles on topics including longevity and biohacking for Eccentric Club blog. He helps to steward the Foresight Institute Biotech & Health Extension world-class working group and is involved in the European Longevity Initiative. He has years of experience working in startups and attended the well-known 500 Startups accelerator in Silicon Valley. He is actively using his insight to build a personal portfolio of promising startups including Revolut, NowRx, Hypersciences, Small Robot Company, or LifeLength.

Having developed a curiosity for the biology of aging at an early age, Naftali has over eight years of experience conducting aging research in topics ranging from human genetics and gene editing to stem cell and tissue regeneration. He is currently pursuing a Ph.D. in the Harvard stem cell and regenerative biology department and holds a B.S. in molecular and cellular biology from Johns Hopkins University. He has also conducted research at the National Institute of Aging (NIA) and he currently serves as an intern and scientific advisor at LongevityTech.Fund.

A PhD student at Yale University with a cumulative experience of 7 years embedding Data Science and Artificial Intelligence to the Biomedical space, Raghav is an expert in understanding and evaluating Computational Biomedical technologies. Over the last few years Raghav has been using his skills to build the next generation of Epigenetic based Aging Biomarkers that explain heterogeneity in Aging and Ageotypes for which he has received multiple grants and fellowships such as the Gruber fellowship, Impetus Aging grant and more. Raghav has also been closely involved in building and managing multiple Biomedical Data Science startups from Series A to pre-seed funding stage. Raghav is also deeply involved in the entrepreneurship and investment ecosystem at Yale as a fellow at Yale’s tech-transfer and investments office. His ultimate goal through his work is to identify and build the next generation of technologies that will transform human health.

Jakub is an investor increasing his expertise pursuing a Master’s degree at Stockholm School of Economics. He finished his undergraduate at Charles University in Prague  and joined LongevityTech.Fund as an intern. He is currently responsible for fundraising and investor relations administration. He has built a personal portfolio focusing on the FinTech industry with startups like Klarna, Plum, Crowdcube, Seedrs, Freetrade, Curve, EstateGuru, Mintos and others.

Vit is a multidisciplinary whose strengths lie in being positioned at the intersection of important domains. After successful careers in design, advertisement, and digital product development where his work was seen, engaged with, and used by hundreds of millions - he’s adding to the mix his business background and the fact that he has been building an active interest in longevity for almost a decade. Vit is an avid science and technology fan, was listed for his successes in Forbes 30 under 30, worked for Adidas, Facebook, and artist Kanye West. He is attending NASA’s Deep Space Food Challenge.

Doctor, scientist and entrepreneur engaging in multiple facets of healthcare. His work in the Department of Hygiene and Preventive Medicine at Charles University in Prague focuses on aging. He acquired his knowledge of the longevity topic thanks to his own work and research as well as thanks to talking to the experts in the field and attending international conferences (i.e. Longevity World Forum in Valencia or EUROTOX in Helsinki). He co-authored a large number of publications in international impact journals. He also co-founded a startup trying to modernize primary care with the aim of enabling personalized and preventative medicine.